WINOX (06838) announced its interim results, reporting a net loss of HKD 45.388 million, an increase of 228.4% year-on-year.
Yongli Shi (06838) announced its mid-term results for 2026, reporting revenue of approximately HKD 152 million, a year-on-year decrease of 53.1%. Gross profit was HKD 19.177 million, down 66.7% compared to the same period last year. The net loss was HKD 45.388 million, an increase of 228.4% year-on-year; the basic loss per share was HKD 0.076.
WINOX (06838) announced its mid-year results for 2026, with revenue of approximately HK$152 million, a year-on-year decrease of 53.1%. Gross profit was HK$19.177 million, down 66.7% compared to the previous year. Net loss was HK$45.388 million, an increase of 228.4% year-on-year; basic loss per share was 7.6 HK cents.
Related Articles

BIOHEART-B (02185) released its interim results, reporting a pre-tax loss of 33.375 million yuan, an increase of 21.72% year-on-year.
.png)
ELIFE HLDGS (00223): Feng Zhibin appointed as chairman

CDB INT'L INV (01062) announced its interim results, reporting a net loss of HKD 90.7287 million, an increase of approximately 6.77 times year-on-year.
BIOHEART-B (02185) released its interim results, reporting a pre-tax loss of 33.375 million yuan, an increase of 21.72% year-on-year.

ELIFE HLDGS (00223): Feng Zhibin appointed as chairman
.png)
CDB INT'L INV (01062) announced its interim results, reporting a net loss of HKD 90.7287 million, an increase of approximately 6.77 times year-on-year.

RECOMMEND





